Noteworthy Thursday Option Activity: BULL, MP, CHTR

Unusual options activity is concentrated in MP Materials (MP) and Charter Communications (CHTR). MP options show 52,245 contracts traded today (~5.2M underlying shares), equal to ~52.3% of MP's one‑month average daily volume (10.0M shares), led by 4,245 contracts in the $60 call expiring Jan 30, 2026 (~424,500 shares). CHTR options show 9,365 contracts (~936,500 underlying shares), ~51.3% of its one‑month average daily volume (1.8M shares), with 2,103 contracts in the $192.50 call expiring Feb 20, 2026 (~210,300 shares). The flows indicate concentrated call positioning but the report is descriptive market-flow data rather than company fundamental news.

Analysis

Market structure: The concentration of long-dated calls (MP Jan 30 2026 $60; CHTR Feb 20 2026 $192.50) implies large directional or hedging bets that will force delta-hedging flows into underlying equity over months, benefiting liquidity providers and long-equity holders if flows persist. MP (rare earths/materials) stands to gain from a demand narrative (EV/smartphone supply chains) while peers with weaker project pipelines could be relatively hurt; CHTR benefits from any M&A or buyback speculation while cable peers face competitive pressure. Cross-asset impacts are modest but measurable: elevated implied vol curves in both names can widen equity option skews, push temporary repo usage up for hedging, and for MP may presage tighter spreads in specialty magnet commodity markets if bullish conviction is real.

Risk assessment: Tail risks include regulatory permitting or environmental delays for MP and FCC/antitrust moves or subscriber losses for CHTR; a 20–40% adverse move in shares would severely damage long-call convexity and force option sellers to unwind. Short-term (days–weeks) the main risk is IV crush or market-maker gamma rebalancing creating exaggerated moves; medium-term (3–9 months) fundamentals (rare earth price shifts, cable ARPU trends) dominate. Hidden dependency: large institutional blocks could be synthetic positions or collateral for convertible issuance, not pure directional bets — examine block trade prints and clearing firms to distinguish.

Trade implications: For directional exposure with limited capital, prefer defined-risk call spreads that capture the expressed conviction while limiting IV decay: e.g., MP Jan30 2026 $60/$80 call spread (allocate 1–2% portfolio, hold to Jan 2026) and CHTR Feb20 2026 $192.50/$230 call spread (1–1.5% allocation). If you believe flows are transient, sell short-dated (30–60 day) strangles against high IV to collect premium, but size conservatively (max 0.5% per name) due to pinch risk. Pair trade: long MP equity (1–2%) vs short XLB (materials ETF) 0.5–1% to isolate idiosyncratic upside in rare earths vs broad materials weakness.

Contrarian angles: The consensus reads these prints as bullish, but they may be dealer-driven hedges or buybacks; if open interest growth outpaces real money buying by >30% without fundamentals shifting, the rally could be mean-reverting. Historical parallels (gamma squeezes in 2020–21) show that price moves driven by options can reverse sharply at expiry — avoid levering into expiries and watch IV term structure; unintended consequence: retail chasing could create expiry pin risk and violent intraday reversals.

Key Decisions for Investors

• Establish a defined-risk bull-call spread in MP: buy Jan 30 2026 $60/$80 call spread sized to 1–2% of portfolio notional, hold to expiry or until fundamental catalyst (rare-earth price surge or permitting news) — exit if MP falls >25% from entry or IV drops >30% within 30 days.
• Establish a tactical call-spread in CHTR: buy Feb 20 2026 $192.50/$230 call spread at 1–1.5% portfolio size, target 30–60% upside return by Feb 2026, cut losses at 40% of premium paid or if company issues negative subscriber guidance.
• If you expect flow-driven mean reversion, sell short-dated (30–60 day) OTM strangles against MP and CHTR sized to 0.5% portfolio each, hedge with delta hedges weekly, and close positions if IV term structure in either name steepens by >20%.